Hyperthermia Devices Market By Product (Microwave Hyperthermia Devices, Ultrasound Hyperthermia Devices) , By Application (Breast Cancer, Prostate Cancer, Cervical Cancer, Others) By End User (Hospitals, Cancer treatment centers, Others) : Global Opportu

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,425	290 Pages	Allied Market Research	December, 2024	ALMR19510667

Best Price Guarantee
Price	from $4,425
Length	290 Pages
Publisher	Allied Market Research
Published Date	December, 2024
SKU	ALMR19510667

Hyperthermia Devices Market By Product (Microwave Hyperthermia Devices, Ultrasound Hyperthermia Devices) , By Application (Breast Cancer, Prostate Cancer, Cervical Cancer, Others) By End User (Hospitals, Cancer treatment centers, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033

The hyperthermia devices market was valued at $168.2 million in 2023, and is projected to reach $290.1 million by 2033, growing at a CAGR of 5.6% from 2024 to 2033.

Hyperthermia devices are medical instruments used to raise the temperature of body tissues for therapeutic purposes, often as an adjunct treatment for cancer. By applying controlled heat to specific areas of the body, these devices enhance the efficacy of treatments like chemotherapy and radiation therapy by improving blood flow and increasing the sensitivity of cancer cells to treatment.

The growth of the global hyperthermia devices market is driven by global increase in cancer cases has driven demand for innovative treatment modalities, including hyperthermia devices, which improve the efficacy of traditional cancer therapies like chemotherapy and radiation. According to a 2022 study published by the World Health Organization, cancer is a leading cause of death worldwide, which accounted for nearly 10 million deaths in 2020. Thus, with patients increasingly seeking less invasive cancer treatments, hyperthermia devices have gained popularity due to their ability to target localized tissues with minimal side effects compared to conventional approaches. In addition, increase in awareness about the benefits of hyperthermia therapy, including its role in enhancing treatment outcomes and reducing side effects, has led to higher acceptance in clinical practice. Moreover, rise in awareness about the benefits of hyperthermia therapy, including its role in enhancing treatment outcomes and reducing side effects, has led to higher acceptance in clinical practice, thus fostering the market growth. Furthermore, surge in geriatric population acts as the key driving force of the global market. This is attributed to the fact that aging is associated with a decline in immune system efficiency, including reduced surveillance for abnormal or cancerous cells. This has created a significant demand for advanced therapeutic options, including hyperthermia devices. A 2024 study published by the World Health Organization revealed that the number of aged individuals will increase from 1 billion in 2020 to 1.4 billion by 2030. Moreover, the number of individuals aging 80 years and older is estimated to reach 426 million by 2050. The growth of specialized oncology clinics and hospitals worldwide has further facilitated the adoption of advanced cancer treatment modalities, such as hyperthermia therapy, to improve patient outcomes. Despite its benefits, hyperthermia therapy remains underutilized due to limited awareness and training among healthcare providers about its effectiveness and integration into cancer treatment protocols. The cost of hyperthermia treatment, including the devices and associated procedures, can be prohibitive for many patients and healthcare systems, particularly in low- and middle-income regions, further restraining the market growth. On the contrary, Technological innovations, such as improved thermal delivery systems, real-time temperature monitoring, and non-invasive devices, have enhanced the safety, precision, and effectiveness of hyperthermia treatments. Such developments are expected to offer remunerative opportunities for the expansion of the global market during the forecast period.

The global hyperthermia devices market analysis is segmented into product, application, end user, and region. On the basis of product, the market is categorized into microwave hyperthermia devices and ultrasound hyperthermia devices. Depending on application, it is segregated into breast cancer, prostate cancer, cervical cancer, and others. By end user, it is fragmented into hospitals, cancer treatment centers, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of product, the ultrasound hyperthermia devices segment is expected to dominate the market from 2024 to 2033.

Depending on application, the prostate cancer segment is anticipated to exhibit the highest growth throughout the forecast period.

By end user, the hospitals segment is projected to grow at a notable pace during the forecast period.

Region wise, North America held the largest market share, in terms of revenue, in 2023, and is likely to dominate the market during the forecast period.

Competition Analysis

The major players operating in the global hyperthermia devices Market include Pyrexar Medical, Oncotherm, Celsius42, Andromedic, Pearson, Nanjing Greathope, Shanghai Huayuan, MagForce AG, Nanopores, and Sensius. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.

Key Market Segments

By Product

Microwave Hyperthermia Devices
Ultrasound Hyperthermia Devices

By Application

Breast Cancer
Prostate Cancer
Cervical Cancer
Others

By End User

Hospitals
Cancer treatment centers
Others

By Region

North America
U.S.
Canada
Mexico
Europe
France
Germany
Italy
Spain
UK
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Brazil
South Africa
Saudi Arabia
Rest of LAMEA

Key Market Players

Pyrexar Medical
Oncotherm
Celsius42
Andromedic
Pearson
Nanjing Greathope
Shanghai Huayuan
MagForce AG
Nanopores
Sensius

CHAPTER 1: INTRODUCTION: 1.1. Report Description; 1.2. Key Market Segments; 1.3. Key Benefits; 1.4. Research Methodology; 1.4.1. Primary Research; 1.4.2. Secondary Research; 1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY: 2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE: 3.1. Market Definition and Scope; 3.2. Key Findings; 3.2.1. Top Investment Pockets; 3.2.2. Top Winning Strategies; 3.3. Porter's Five Forces Analysis; 3.3.1. Bargaining Power of Suppliers; 3.3.2. Threat of New Entrants; 3.3.3. Threat of Substitutes; 3.3.4. Competitive Rivalry; 3.3.5. Bargaining Power among Buyers; 3.4. Market Dynamics; 3.4.1. Drivers; 3.4.2. Restraints; 3.4.3. Opportunities
CHAPTER 4: HYPERTHERMIA DEVICES MARKET, BY PRODUCT: 4.1. Market Overview; 4.1.1 Market Size and Forecast, By Product; 4.2. Microwave Hyperthermia Devices; 4.2.1. Key Market Trends, Growth Factors and Opportunities; 4.2.2. Market Size and Forecast, By Region; 4.2.3. Market Share Analysis, By Country; 4.3. Ultrasound Hyperthermia Devices; 4.3.1. Key Market Trends, Growth Factors and Opportunities; 4.3.2. Market Size and Forecast, By Region; 4.3.3. Market Share Analysis, By Country
CHAPTER 5: HYPERTHERMIA DEVICES MARKET, BY APPLICATION: 5.1. Market Overview; 5.1.1 Market Size and Forecast, By Application; 5.2. Breast Cancer; 5.2.1. Key Market Trends, Growth Factors and Opportunities; 5.2.2. Market Size and Forecast, By Region; 5.2.3. Market Share Analysis, By Country; 5.3. Prostate Cancer; 5.3.1. Key Market Trends, Growth Factors and Opportunities; 5.3.2. Market Size and Forecast, By Region; 5.3.3. Market Share Analysis, By Country; 5.4. Cervical Cancer; 5.4.1. Key Market Trends, Growth Factors and Opportunities; 5.4.2. Market Size and Forecast, By Region; 5.4.3. Market Share Analysis, By Country; 5.5. Others; 5.5.1. Key Market Trends, Growth Factors and Opportunities; 5.5.2. Market Size and Forecast, By Region; 5.5.3. Market Share Analysis, By Country
CHAPTER 6: HYPERTHERMIA DEVICES MARKET, BY END USER: 6.1. Market Overview; 6.1.1 Market Size and Forecast, By End User; 6.2. Hospitals; 6.2.1. Key Market Trends, Growth Factors and Opportunities; 6.2.2. Market Size and Forecast, By Region; 6.2.3. Market Share Analysis, By Country; 6.3. Cancer Treatment Centers; 6.3.1. Key Market Trends, Growth Factors and Opportunities; 6.3.2. Market Size and Forecast, By Region; 6.3.3. Market Share Analysis, By Country; 6.4. Others; 6.4.1. Key Market Trends, Growth Factors and Opportunities; 6.4.2. Market Size and Forecast, By Region; 6.4.3. Market Share Analysis, By Country
CHAPTER 7: HYPERTHERMIA DEVICES MARKET, BY REGION: 7.1. Market Overview; 7.1.1 Market Size and Forecast, By Region; 7.2. North America; 7.2.1. Key Market Trends and Opportunities; 7.2.2. Market Size and Forecast, By Product; 7.2.3. Market Size and Forecast, By Application; 7.2.4. Market Size and Forecast, By End User; 7.2.5. Market Size and Forecast, By Country; 7.2.6. U.S. Hyperthermia Devices Market; 7.2.6.1. Market Size and Forecast, By Product; 7.2.6.2. Market Size and Forecast, By Application; 7.2.6.3. Market Size and Forecast, By End User; 7.2.7. Canada Hyperthermia Devices Market; 7.2.7.1. Market Size and Forecast, By Product; 7.2.7.2. Market Size and Forecast, By Application; 7.2.7.3. Market Size and Forecast, By End User; 7.2.8. Mexico Hyperthermia Devices Market; 7.2.8.1. Market Size and Forecast, By Product; 7.2.8.2. Market Size and Forecast, By Application; 7.2.8.3. Market Size and Forecast, By End User; 7.3. Europe; 7.3.1. Key Market Trends and Opportunities; 7.3.2. Market Size and Forecast, By Product; 7.3.3. Market Size and Forecast, By Application; 7.3.4. Market Size and Forecast, By End User; 7.3.5. Market Size and Forecast, By Country; 7.3.6. France Hyperthermia Devices Market; 7.3.6.1. Market Size and Forecast, By Product; 7.3.6.2. Market Size and Forecast, By Application; 7.3.6.3. Market Size and Forecast, By End User; 7.3.7. Germany Hyperthermia Devices Market; 7.3.7.1. Market Size and Forecast, By Product; 7.3.7.2. Market Size and Forecast, By Application; 7.3.7.3. Market Size and Forecast, By End User; 7.3.8. Italy Hyperthermia Devices Market; 7.3.8.1. Market Size and Forecast, By Product; 7.3.8.2. Market Size and Forecast, By Application; 7.3.8.3. Market Size and Forecast, By End User; 7.3.9. Spain Hyperthermia Devices Market; 7.3.9.1. Market Size and Forecast, By Product; 7.3.9.2. Market Size and Forecast, By Application; 7.3.9.3. Market Size and Forecast, By End User; 7.3.10. UK Hyperthermia Devices Market; 7.3.10.1. Market Size and Forecast, By Product; 7.3.10.2. Market Size and Forecast, By Application; 7.3.10.3. Market Size and Forecast, By End User; 7.3.11. Rest Of Europe Hyperthermia Devices Market; 7.3.11.1. Market Size and Forecast, By Product; 7.3.11.2. Market Size and Forecast, By Application; 7.3.11.3. Market Size and Forecast, By End User; 7.4. Asia-Pacific; 7.4.1. Key Market Trends and Opportunities; 7.4.2. Market Size and Forecast, By Product; 7.4.3. Market Size and Forecast, By Application; 7.4.4. Market Size and Forecast, By End User; 7.4.5. Market Size and Forecast, By Country; 7.4.6. China Hyperthermia Devices Market; 7.4.6.1. Market Size and Forecast, By Product; 7.4.6.2. Market Size and Forecast, By Application; 7.4.6.3. Market Size and Forecast, By End User; 7.4.7. Japan Hyperthermia Devices Market; 7.4.7.1. Market Size and Forecast, By Product; 7.4.7.2. Market Size and Forecast, By Application; 7.4.7.3. Market Size and Forecast, By End User; 7.4.8. India Hyperthermia Devices Market; 7.4.8.1. Market Size and Forecast, By Product; 7.4.8.2. Market Size and Forecast, By Application; 7.4.8.3. Market Size and Forecast, By End User; 7.4.9. South Korea Hyperthermia Devices Market; 7.4.9.1. Market Size and Forecast, By Product; 7.4.9.2. Market Size and Forecast, By Application; 7.4.9.3. Market Size and Forecast, By End User; 7.4.10. Australia Hyperthermia Devices Market; 7.4.10.1. Market Size and Forecast, By Product; 7.4.10.2. Market Size and Forecast, By Application; 7.4.10.3. Market Size and Forecast, By End User; 7.4.11. Rest of Asia-Pacific Hyperthermia Devices Market; 7.4.11.1. Market Size and Forecast, By Product; 7.4.11.2. Market Size and Forecast, By Application; 7.4.11.3. Market Size and Forecast, By End User; 7.5. LAMEA; 7.5.1. Key Market Trends and Opportunities; 7.5.2. Market Size and Forecast, By Product; 7.5.3. Market Size and Forecast, By Application; 7.5.4. Market Size and Forecast, By End User; 7.5.5. Market Size and Forecast, By Country; 7.5.6. Brazil Hyperthermia Devices Market; 7.5.6.1. Market Size and Forecast, By Product; 7.5.6.2. Market Size and Forecast, By Application; 7.5.6.3. Market Size and Forecast, By End User; 7.5.7. South Africa Hyperthermia Devices Market; 7.5.7.1. Market Size and Forecast, By Product; 7.5.7.2. Market Size and Forecast, By Application; 7.5.7.3. Market Size and Forecast, By End User; 7.5.8. Saudi Arabia Hyperthermia Devices Market; 7.5.8.1. Market Size and Forecast, By Product; 7.5.8.2. Market Size and Forecast, By Application; 7.5.8.3. Market Size and Forecast, By End User; 7.5.9. Rest of LAMEA Hyperthermia Devices Market; 7.5.9.1. Market Size and Forecast, By Product; 7.5.9.2. Market Size and Forecast, By Application; 7.5.9.3. Market Size and Forecast, By End User
CHAPTER 8: COMPETITIVE LANDSCAPE: 8.1. Introduction; 8.2. Top Winning Strategies; 8.3. Product Mapping Of Top 10 Player; 8.4. Competitive Dashboard; 8.5. Competitive Heatmap; 8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES: 9.1. Pyrexar Medical; 9.1.1. Company Overview; 9.1.2. Key Executives; 9.1.3. Company Snapshot; 9.1.4. Operating Business Segments; 9.1.5. Product Portfolio; 9.1.6. Business Performance; 9.1.7. Key Strategic Moves and Developments; 9.2. Oncotherm; 9.2.1. Company Overview; 9.2.2. Key Executives; 9.2.3. Company Snapshot; 9.2.4. Operating Business Segments; 9.2.5. Product Portfolio; 9.2.6. Business Performance; 9.2.7. Key Strategic Moves and Developments; 9.3. Celsius42; 9.3.1. Company Overview; 9.3.2. Key Executives; 9.3.3. Company Snapshot; 9.3.4. Operating Business Segments; 9.3.5. Product Portfolio; 9.3.6. Business Performance; 9.3.7. Key Strategic Moves and Developments; 9.4. Andromedic; 9.4.1. Company Overview; 9.4.2. Key Executives; 9.4.3. Company Snapshot; 9.4.4. Operating Business Segments; 9.4.5. Product Portfolio; 9.4.6. Business Performance; 9.4.7. Key Strategic Moves and Developments; 9.5. Pearson; 9.5.1. Company Overview; 9.5.2. Key Executives; 9.5.3. Company Snapshot; 9.5.4. Operating Business Segments; 9.5.5. Product Portfolio; 9.5.6. Business Performance; 9.5.7. Key Strategic Moves and Developments; 9.6. Nanjing Greathope; 9.6.1. Company Overview; 9.6.2. Key Executives; 9.6.3. Company Snapshot; 9.6.4. Operating Business Segments; 9.6.5. Product Portfolio; 9.6.6. Business Performance; 9.6.7. Key Strategic Moves and Developments; 9.7. Shanghai Huayuan; 9.7.1. Company Overview; 9.7.2. Key Executives; 9.7.3. Company Snapshot; 9.7.4. Operating Business Segments; 9.7.5. Product Portfolio; 9.7.6. Business Performance; 9.7.7. Key Strategic Moves and Developments; 9.8. MagForce AG; 9.8.1. Company Overview; 9.8.2. Key Executives; 9.8.3. Company Snapshot; 9.8.4. Operating Business Segments; 9.8.5. Product Portfolio; 9.8.6. Business Performance; 9.8.7. Key Strategic Moves and Developments; 9.9. Nanopores; 9.9.1. Company Overview; 9.9.2. Key Executives; 9.9.3. Company Snapshot; 9.9.4. Operating Business Segments; 9.9.5. Product Portfolio; 9.9.6. Business Performance; 9.9.7. Key Strategic Moves and Developments; 9.10. Sensius; 9.10.1. Company Overview; 9.10.2. Key Executives; 9.10.3. Company Snapshot; 9.10.4. Operating Business Segments; 9.10.5. Product Portfolio; 9.10.6. Business Performance; 9.10.7. Key Strategic Moves and Developments
LIST OF TABLES: TABLE 1. GLOBAL HYPERTHERMIA DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($MILLION); TABLE 2. HYPERTHERMIA DEVICES MARKET FOR MICROWAVE HYPERTHERMIA DEVICES, BY REGION, 2024 - 2033 ($MILLION); TABLE 3. HYPERTHERMIA DEVICES MARKET FOR ULTRASOUND HYPERTHERMIA DEVICES, BY REGION, 2024 - 2033 ($MILLION); TABLE 4. GLOBAL HYPERTHERMIA DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 5. HYPERTHERMIA DEVICES MARKET FOR BREAST CANCER, BY REGION, 2024 - 2033 ($MILLION); TABLE 6. HYPERTHERMIA DEVICES MARKET FOR PROSTATE CANCER, BY REGION, 2024 - 2033 ($MILLION); TABLE 7. HYPERTHERMIA DEVICES MARKET FOR CERVICAL CANCER, BY REGION, 2024 - 2033 ($MILLION); TABLE 8. HYPERTHERMIA DEVICES MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($MILLION); TABLE 9. GLOBAL HYPERTHERMIA DEVICES MARKET, BY END USER, 2024 - 2033 ($MILLION); TABLE 10. HYPERTHERMIA DEVICES MARKET FOR HOSPITALS, BY REGION, 2024 - 2033 ($MILLION); TABLE 11. HYPERTHERMIA DEVICES MARKET FOR CANCER TREATMENT CENTERS, BY REGION, 2024 - 2033 ($MILLION); TABLE 12. HYPERTHERMIA DEVICES MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($MILLION); TABLE 13. HYPERTHERMIA DEVICES MARKET, BY REGION, 2024 - 2033 ($MILLION); TABLE 14. NORTH AMERICA HYPERTHERMIA DEVICES MARKET, BY COUNTRY, 2024 - 2033 ($MILLION); TABLE 15. NORTH AMERICA HYPERTHERMIA DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($MILLION); TABLE 16. NORTH AMERICA HYPERTHERMIA DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 17. NORTH AMERICA HYPERTHERMIA DEVICES MARKET, BY END USER, 2024 - 2033 ($MILLION); TABLE 18. U.S. HYPERTHERMIA DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($MILLION); TABLE 19. U.S. HYPERTHERMIA DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 20. U.S. HYPERTHERMIA DEVICES MARKET, BY END USER, 2024 - 2033 ($MILLION); TABLE 21. CANADA HYPERTHERMIA DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($MILLION); TABLE 22. CANADA HYPERTHERMIA DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 23. CANADA HYPERTHERMIA DEVICES MARKET, BY END USER, 2024 - 2033 ($MILLION); TABLE 24. MEXICO HYPERTHERMIA DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($MILLION); TABLE 25. MEXICO HYPERTHERMIA DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 26. MEXICO HYPERTHERMIA DEVICES MARKET, BY END USER, 2024 - 2033 ($MILLION); TABLE 27. EUROPE HYPERTHERMIA DEVICES MARKET, BY COUNTRY, 2024 - 2033 ($MILLION); TABLE 28. EUROPE HYPERTHERMIA DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($MILLION); TABLE 29. EUROPE HYPERTHERMIA DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 30. EUROPE HYPERTHERMIA DEVICES MARKET, BY END USER, 2024 - 2033 ($MILLION); TABLE 31. FRANCE HYPERTHERMIA DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($MILLION); TABLE 32. FRANCE HYPERTHERMIA DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 33. FRANCE HYPERTHERMIA DEVICES MARKET, BY END USER, 2024 - 2033 ($MILLION); TABLE 34. GERMANY HYPERTHERMIA DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($MILLION); TABLE 35. GERMANY HYPERTHERMIA DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 36. GERMANY HYPERTHERMIA DEVICES MARKET, BY END USER, 2024 - 2033 ($MILLION); TABLE 37. ITALY HYPERTHERMIA DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($MILLION); TABLE 38. ITALY HYPERTHERMIA DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 39. ITALY HYPERTHERMIA DEVICES MARKET, BY END USER, 2024 - 2033 ($MILLION); TABLE 40. SPAIN HYPERTHERMIA DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($MILLION); TABLE 41. SPAIN HYPERTHERMIA DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 42. SPAIN HYPERTHERMIA DEVICES MARKET, BY END USER, 2024 - 2033 ($MILLION); TABLE 43. UK HYPERTHERMIA DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($MILLION); TABLE 44. UK HYPERTHERMIA DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 45. UK HYPERTHERMIA DEVICES MARKET, BY END USER, 2024 - 2033 ($MILLION); TABLE 46. REST OF EUROPE HYPERTHERMIA DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($MILLION); TABLE 47. REST OF EUROPE HYPERTHERMIA DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 48. REST OF EUROPE HYPERTHERMIA DEVICES MARKET, BY END USER, 2024 - 2033 ($MILLION); TABLE 49. ASIA-PACIFIC HYPERTHERMIA DEVICES MARKET, BY COUNTRY, 2024 - 2033 ($MILLION); TABLE 50. ASIA-PACIFIC HYPERTHERMIA DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($MILLION); TABLE 51. ASIA-PACIFIC HYPERTHERMIA DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 52. ASIA-PACIFIC HYPERTHERMIA DEVICES MARKET, BY END USER, 2024 - 2033 ($MILLION); TABLE 53. CHINA HYPERTHERMIA DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($MILLION); TABLE 54. CHINA HYPERTHERMIA DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 55. CHINA HYPERTHERMIA DEVICES MARKET, BY END USER, 2024 - 2033 ($MILLION); TABLE 56. JAPAN HYPERTHERMIA DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($MILLION); TABLE 57. JAPAN HYPERTHERMIA DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 58. JAPAN HYPERTHERMIA DEVICES MARKET, BY END USER, 2024 - 2033 ($MILLION); TABLE 59. INDIA HYPERTHERMIA DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($MILLION); TABLE 60. INDIA HYPERTHERMIA DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 61. INDIA HYPERTHERMIA DEVICES MARKET, BY END USER, 2024 - 2033 ($MILLION); TABLE 62. SOUTH KOREA HYPERTHERMIA DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($MILLION); TABLE 63. SOUTH KOREA HYPERTHERMIA DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 64. SOUTH KOREA HYPERTHERMIA DEVICES MARKET, BY END USER, 2024 - 2033 ($MILLION); TABLE 65. AUSTRALIA HYPERTHERMIA DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($MILLION); TABLE 66. AUSTRALIA HYPERTHERMIA DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 67. AUSTRALIA HYPERTHERMIA DEVICES MARKET, BY END USER, 2024 - 2033 ($MILLION); TABLE 68. REST OF ASIA-PACIFIC HYPERTHERMIA DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($MILLION); TABLE 69. REST OF ASIA-PACIFIC HYPERTHERMIA DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 70. REST OF ASIA-PACIFIC HYPERTHERMIA DEVICES MARKET, BY END USER, 2024 - 2033 ($MILLION); TABLE 71. LAMEA HYPERTHERMIA DEVICES MARKET, BY COUNTRY, 2024 - 2033 ($MILLION); TABLE 72. LAMEA HYPERTHERMIA DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($MILLION); TABLE 73. LAMEA HYPERTHERMIA DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 74. LAMEA HYPERTHERMIA DEVICES MARKET, BY END USER, 2024 - 2033 ($MILLION); TABLE 75. BRAZIL HYPERTHERMIA DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($MILLION); TABLE 76. BRAZIL HYPERTHERMIA DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 77. BRAZIL HYPERTHERMIA DEVICES MARKET, BY END USER, 2024 - 2033 ($MILLION); TABLE 78. SOUTH AFRICA HYPERTHERMIA DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($MILLION); TABLE 79. SOUTH AFRICA HYPERTHERMIA DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 80. SOUTH AFRICA HYPERTHERMIA DEVICES MARKET, BY END USER, 2024 - 2033 ($MILLION); TABLE 81. SAUDI ARABIA HYPERTHERMIA DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($MILLION); TABLE 82. SAUDI ARABIA HYPERTHERMIA DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 83. SAUDI ARABIA HYPERTHERMIA DEVICES MARKET, BY END USER, 2024 - 2033 ($MILLION); TABLE 84. REST OF LAMEA HYPERTHERMIA DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($MILLION); TABLE 85. REST OF LAMEA HYPERTHERMIA DEVICES MARKET, BY APPLICATION, 2024 - 2033 ($MILLION); TABLE 86. REST OF LAMEA HYPERTHERMIA DEVICES MARKET, BY END USER, 2024 - 2033 ($MILLION); TABLE 87. PYREXAR MEDICAL: KEY EXECUTIVES; TABLE 88. PYREXAR MEDICAL: COMPANY SNAPSHOT; TABLE 89. PYREXAR MEDICAL: OPERATING SEGMENTS; TABLE 90. PYREXAR MEDICAL: PRODUCT PORTFOLIO; TABLE 91. PYREXAR MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS; TABLE 92. ONCOTHERM: KEY EXECUTIVES; TABLE 93. ONCOTHERM: COMPANY SNAPSHOT; TABLE 94. ONCOTHERM: OPERATING SEGMENTS; TABLE 95. ONCOTHERM: PRODUCT PORTFOLIO; TABLE 96. ONCOTHERM: KEY STRATEGIC MOVES AND DEVELOPMENTS; TABLE 97. CELSIUS42: KEY EXECUTIVES; TABLE 98. CELSIUS42: COMPANY SNAPSHOT; TABLE 99. CELSIUS42: OPERATING SEGMENTS; TABLE 100. CELSIUS42: PRODUCT PORTFOLIO; TABLE 101. CELSIUS42: KEY STRATEGIC MOVES AND DEVELOPMENTS; TABLE 102. ANDROMEDIC: KEY EXECUTIVES; TABLE 103. ANDROMEDIC: COMPANY SNAPSHOT; TABLE 104. ANDROMEDIC: OPERATING SEGMENTS; TABLE 105. ANDROMEDIC: PRODUCT PORTFOLIO; TABLE 106. ANDROMEDIC: KEY STRATEGIC MOVES AND DEVELOPMENTS; TABLE 107. PEARSON: KEY EXECUTIVES; TABLE 108. PEARSON: COMPANY SNAPSHOT; TABLE 109. PEARSON: OPERATING SEGMENTS; TABLE 110. PEARSON: PRODUCT PORTFOLIO; TABLE 111. PEARSON: KEY STRATEGIC MOVES AND DEVELOPMENTS; TABLE 112. NANJING GREATHOPE: KEY EXECUTIVES; TABLE 113. NANJING GREATHOPE: COMPANY SNAPSHOT; TABLE 114. NANJING GREATHOPE: OPERATING SEGMENTS; TABLE 115. NANJING GREATHOPE: PRODUCT PORTFOLIO; TABLE 116. NANJING GREATHOPE: KEY STRATEGIC MOVES AND DEVELOPMENTS; TABLE 117. SHANGHAI HUAYUAN: KEY EXECUTIVES; TABLE 118. SHANGHAI HUAYUAN: COMPANY SNAPSHOT; TABLE 119. SHANGHAI HUAYUAN: OPERATING SEGMENTS; TABLE 120. SHANGHAI HUAYUAN: PRODUCT PORTFOLIO; TABLE 121. SHANGHAI HUAYUAN: KEY STRATEGIC MOVES AND DEVELOPMENTS; TABLE 122. MAGFORCE AG: KEY EXECUTIVES; TABLE 123. MAGFORCE AG: COMPANY SNAPSHOT; TABLE 124. MAGFORCE AG: OPERATING SEGMENTS; TABLE 125. MAGFORCE AG: PRODUCT PORTFOLIO; TABLE 126. MAGFORCE AG: KEY STRATEGIC MOVES AND DEVELOPMENTS; TABLE 127. NANOPORES: KEY EXECUTIVES; TABLE 128. NANOPORES: COMPANY SNAPSHOT; TABLE 129. NANOPORES: OPERATING SEGMENTS; TABLE 130. NANOPORES: PRODUCT PORTFOLIO; TABLE 131. NANOPORES: KEY STRATEGIC MOVES AND DEVELOPMENTS; TABLE 132. SENSIUS: KEY EXECUTIVES; TABLE 133. SENSIUS: COMPANY SNAPSHOT; TABLE 134. SENSIUS: OPERATING SEGMENTS; TABLE 135. SENSIUS: PRODUCT PORTFOLIO; TABLE 136. SENSIUS: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES: FIGURE 1. GLOBAL HYPERTHERMIA DEVICES MARKET, 2024 - 2033; FIGURE 2. SEGMENTATION OF HYPERTHERMIA DEVICES MARKET, 2024 - 2033; FIGURE 3. TOP INVESTMENT POCKET IN HYPERTHERMIA DEVICES MARKET; FIGURE 4. MODERATE BARGAINING POWER OF BUYERS; FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS; FIGURE 6. MODERATE THREAT OF NEW ENTRANTS; FIGURE 7. LOW THREAT OF SUBSTITUTION; FIGURE 8. HIGH COMPETITIVE RIVALRY; FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALHYPERTHERMIA DEVICES MARKET; FIGURE 10. GLOBAL HYPERTHERMIA DEVICES MARKET SEGMENTATION, BY PRODUCT; FIGURE 11. HYPERTHERMIA DEVICES MARKET FOR MICROWAVE HYPERTHERMIA DEVICES, BY COUNTRY, 2024 - 2033 ($MILLION); FIGURE 12. HYPERTHERMIA DEVICES MARKET FOR ULTRASOUND HYPERTHERMIA DEVICES, BY COUNTRY, 2024 - 2033 ($MILLION); FIGURE 13. GLOBAL HYPERTHERMIA DEVICES MARKET SEGMENTATION, BY APPLICATION; FIGURE 14. HYPERTHERMIA DEVICES MARKET FOR BREAST CANCER, BY COUNTRY, 2024 - 2033 ($MILLION); FIGURE 15. HYPERTHERMIA DEVICES MARKET FOR PROSTATE CANCER, BY COUNTRY, 2024 - 2033 ($MILLION); FIGURE 16. HYPERTHERMIA DEVICES MARKET FOR CERVICAL CANCER, BY COUNTRY, 2024 - 2033 ($MILLION); FIGURE 17. HYPERTHERMIA DEVICES MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($MILLION); FIGURE 18. GLOBAL HYPERTHERMIA DEVICES MARKET SEGMENTATION, BY END USER; FIGURE 19. HYPERTHERMIA DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2024 - 2033 ($MILLION); FIGURE 20. HYPERTHERMIA DEVICES MARKET FOR CANCER TREATMENT CENTERS, BY COUNTRY, 2024 - 2033 ($MILLION); FIGURE 21. HYPERTHERMIA DEVICES MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($MILLION); FIGURE 22. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*; FIGURE 23. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*; FIGURE 24. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*; FIGURE 25. PRODUCT MAPPING OF TOP 10 PLAYERS; FIGURE 26. COMPETITIVE DASHBOARD; FIGURE 27. COMPETITIVE HEATMAP: HYPERTHERMIA DEVICES MARKET; FIGURE 28. TOP PLAYER POSITIONING, 2023; FIGURE 29. PYREXAR MEDICAL: NET SALES, 2021-2023 ($MILLION); FIGURE 30. PYREXAR MEDICAL: REVENUE SHARE, BY SEGMENT, 2023 (%); FIGURE 31. PYREXAR MEDICAL: REVENUE SHARE, BY REGION, 2023 (%); FIGURE 32. ONCOTHERM: NET SALES, 2021-2023 ($MILLION); FIGURE 33. ONCOTHERM: REVENUE SHARE, BY SEGMENT, 2023 (%); FIGURE 34. ONCOTHERM: REVENUE SHARE, BY REGION, 2023 (%); FIGURE 35. CELSIUS42: NET SALES, 2021-2023 ($MILLION); FIGURE 36. CELSIUS42: REVENUE SHARE, BY SEGMENT, 2023 (%); FIGURE 37. CELSIUS42: REVENUE SHARE, BY REGION, 2023 (%); FIGURE 38. ANDROMEDIC: NET SALES, 2021-2023 ($MILLION); FIGURE 39. ANDROMEDIC: REVENUE SHARE, BY SEGMENT, 2023 (%); FIGURE 40. ANDROMEDIC: REVENUE SHARE, BY REGION, 2023 (%); FIGURE 41. PEARSON: NET SALES, 2021-2023 ($MILLION); FIGURE 42. PEARSON: REVENUE SHARE, BY SEGMENT, 2023 (%); FIGURE 43. PEARSON: REVENUE SHARE, BY REGION, 2023 (%); FIGURE 44. NANJING GREATHOPE: NET SALES, 2021-2023 ($MILLION); FIGURE 45. NANJING GREATHOPE: REVENUE SHARE, BY SEGMENT, 2023 (%); FIGURE 46. NANJING GREATHOPE: REVENUE SHARE, BY REGION, 2023 (%); FIGURE 47. SHANGHAI HUAYUAN: NET SALES, 2021-2023 ($MILLION); FIGURE 48. SHANGHAI HUAYUAN: REVENUE SHARE, BY SEGMENT, 2023 (%); FIGURE 49. SHANGHAI HUAYUAN: REVENUE SHARE, BY REGION, 2023 (%); FIGURE 50. MAGFORCE AG: NET SALES, 2021-2023 ($MILLION); FIGURE 51. MAGFORCE AG: REVENUE SHARE, BY SEGMENT, 2023 (%); FIGURE 52. MAGFORCE AG: REVENUE SHARE, BY REGION, 2023 (%); FIGURE 53. NANOPORES: NET SALES, 2021-2023 ($MILLION); FIGURE 54. NANOPORES: REVENUE SHARE, BY SEGMENT, 2023 (%); FIGURE 55. NANOPORES: REVENUE SHARE, BY REGION, 2023 (%); FIGURE 56. SENSIUS: NET SALES, 2021-2023 ($MILLION); FIGURE 57. SENSIUS: REVENUE SHARE, BY SEGMENT, 2023 (%); FIGURE 58. SENSIUS: REVENUE SHARE, BY REGION, 2023 (%)